Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility-data from the observational FINNAKI study.

导出 OA

翻译打印收藏纠错

作者： Sanna,Törnblom ^[1] ; Sara,Nisula ^[2] ; Liisa,Petäjä ^[3] ; Suvi T,Vaara ^[2] ; Mikko,Haapio ^[4] ; Eero,Pesonen ^[3] ; Ville,Pettilä ^[2] ; FINNAKI study group

作者单位： Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, PO Box 340, 00029 HUS, Helsinki, Finland. sanna.tornblom@hus.fi. ^[1] Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, PO Box 340, 00029 HUS, Helsinki, Finland. ^[2] Division of Anaesthesiology, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[3] Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[4]

关键词 Acute kidney injury Critical illness Intensive care Neutrophil gelatinase-associated lipocalin Sepsis

DOI 10.1186/s13613-020-00667-7

PMID 32347418

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交